SOCS1 and cancer: Notably, proteins modulated by SOCS1, uniquely in cisplatin-treated cells, showed a significant enrichment of ‘peroxiredoxin activity’ (Supplementary Figure S5), which is recognized as an important pathway in cellular redox homeostasis and is implicated in cancer development and progression [59,60,61].